PlainPharmaWatch

CMS Open Payments · Program Year 2024

Astellas US Technologies

Astellas US Technologies reported $6,859,578.00 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 49 transactions.

See the rankings → How this is sourced
$6.9M
All-tracks total
49
Transactions
0
Recipients
#224
of 1,925 companies

Astellas US Technologies reported $6,859,578.00 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #224 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer astellas-us-technologies Astellas US Technologies

$6.9M · #224/1,925 · 0.0% industry · PY2024

  • TOT $6.9M
  • RANK #224
  • SHARE 0.0%
  • TXN 49
  • RCP 0
  • CAT 0
  • GEN n/a
  • PY 2024

Volume peers

Nearest volume peer: Astellas Pharma Inc ($6.9M)

Dompe Farmaceutici S.p.A.$6.9MAstellas Pharma Inc$6.9MAstellas US Technologies (th…$6.9MJohnson & Johnson Vision Car…$6.8MAptis Medical, LLC$6.8M
All-tracks payment totals near Astellas US Technologies (CMS Open Payments PY2024)

Astellas US Technologies sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Astellas US Technologies

Averaging $140.0K per transaction and $0.00 per recipient, Astellas US Technologies's Program Year 2024 total comes to $6,859,578.00 across 49 transactions and 0 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #224 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Astellas US Technologies.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Astellas US Technologies's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.